Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.43 |
| ▸ | LPL | P06858 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | PLK1 | P53350 | 1/20 | 0.33 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9100129 | 0.83 | CNR1 (0.45) | CNR1CNR2ALOX5LPLLIPG | |
| SCHEMBL9740304 | 0.79 | CNR1 (0.50) | CNR1CNR2ALOX5LPLLIPG | |
| SCHEMBL1069410 | 0.78 | CNR1 (0.45) | CNR1CNR2ALOX5LPLLIPG | |
| SCHEMBL16959716 | 0.78 | TAAR1 (0.41) | — | |
| SCHEMBL8963358 | 0.78 | CNR1 (0.45) | CNR1CNR2ALOX5LPLLIPG | |
| SCHEMBL16959425 | 0.77 | LMNA (0.37) | — | |
| SCHEMBL16956886 | 0.77 | EDNRB (0.37) | — | |
| SCHEMBL16956502 | 0.77 | KCNH2 (0.42) | — | |
| SCHEMBL5255675 | 0.77 | CNR1 (0.44) | CNR1CNR2ALOX5LPLLIPG | |
| SCHEMBL5048783 | 0.76 | CNR1 (0.47) | CNR1CNR2ALOX5LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7064139-B2 | Method for treating retroviral infections | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2006-06-20 | — | — | US | disclosed |
| CN-1036064-C | Benzene derivatives having NGF production-promoting activity | SANKYO CO (JP) | 1997-10-08 | — | — | CN | disclosed |
| US-5643925-A | COGNITION ACTIVATORS AND NERVE GROWTH FACTORS | SANKYO COMPANY, LIMITED (JP) | 1997-07-01 | — | — | US | disclosed |
| US-5614521-A | NERVE GROWTH FACTOR | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| EP-0501656-B1 | New benzene derivatives having (NGF) production-promoting activity | SANKYO CO (JP) | 1997-01-22 | — | — | EP | disclosed |
| CN-1064273-A | The new NGF that has generates the active benzene derivative of promotion | SANKYO CO (JP) | 1992-09-09 | — | — | CN | disclosed |
| EP-0501656-A2 | New benzene derivatives having (NGF) production-promoting activity | Sankyo Company Limited (JP) | 1992-09-02 | — | — | EP | disclosed |